Trials / Completed

CompletedNCT00240006

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

An Open Label, Prospective Parallel Cohort Study Comparing A 90-day Copaxone® Adherence Enhancement Program Among Persons With Multiple Sclerosis Who Participate in Shared Solutions® Alone or in Partnership With Their MS Center

Status: Completed
Phase: Phase 4
Study type: Interventional
Enrollment: 307 (actual)

Sponsor: Teva Neuroscience, Inc. · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

To compare the effectiveness of a 90-day Copaxone® adherence enhancement program for a sample of MS patients who are at high risk of nonadherence and receive support from Shared Solutions® and their MS Center versus those who receive support only from Shared Solutions®.

Conditions

Multiple Sclerosis

Interventions

Type	Name	Description
PROCEDURE	Shared Solutions® plus MS Center v. Shared Solutions®	Copaxone

Timeline

Start date: 2006-01-01
Primary completion: 2007-01-01
Completion: 2007-09-01
First posted: 2005-10-17
Last updated: 2011-04-11

Source: ClinicalTrials.gov record NCT00240006. Inclusion in this directory is not an endorsement.